U.S. Semiconductors Stock News

Stratasys (SSYS) saw its stock price climb after announcing expansions to its 3D-printing business with new acquisitions and progress in aerospace certifications. Broader market optimism and easing trade tensions also played a part in boosting sentiment. See our latest analysis for Stratasys. Stratasys has captured fresh attention not just with headline-grabbing deals, but also by riding a surge in optimism across the sector. Its latest share price, at $11.78, reflects strong momentum, up...

Liberty Energy Inc. ( NYSE:LBRT ) shares have had a really impressive month, gaining 33% after a shaky period...

Netflix (NFLX) posted net profit margins of 24%, up from last year’s 20.7%, signaling improved profitability. Earnings grew 34.1% over the past year, well above the company’s five-year average of 22.3% per year, and are forecast to climb another 17.5% annually, outpacing the expected 15.5% growth rate for the broader US market. With revenue expected to rise 10.7% per year and analysts keeping a close eye on rising profit margins, investors are weighing sustained above-market growth momentum...

FTI Consulting (FCN) posted forecasted earnings growth of 14.04% per year, trailing the broader US market’s anticipated 15.5% pace. Net profit margin came in at 6.8%, down from last year’s 8.9%, with revenue expected to rise 6.5% per year, lower than the US market average of 10%. Against this backdrop, investors are weighing the company’s consistent earnings track record and favorable value metrics, particularly as high earnings quality and growing profits remain in focus, while no...

As major U.S. stock indexes recently ended lower amidst ongoing earnings reports and renewed U.S.-China trade tensions, investors are keenly observing market fluctuations for potential opportunities. In such an environment, identifying undervalued stocks can be a strategic approach, as these equities might offer a margin of safety and potential for appreciation when market conditions stabilize or improve.

Major stock indexes in the United States recently ended lower as investors weighed earnings reports and ongoing U.S.-China trade tensions. In such a fluctuating market, penny stocks—despite their somewhat outdated moniker—remain a compelling area for investment, particularly when they are backed by solid financials. These smaller or newer companies can offer surprising value and potential for growth, making them worth considering for investors seeking hidden opportunities in quality stocks.

In October 2025, the U.S. stock market has been navigating a complex landscape marked by renewed U.S.-China trade tensions and mixed earnings reports, leading to declines in major indices such as the Nasdaq, Dow Jones Industrial Average, and S&P 500. Amidst this backdrop of uncertainty and fluctuating investor sentiment, identifying promising small-cap stocks can offer unique opportunities for those looking to uncover potential growth avenues in less-explored corners of the market.

As the U.S. stock market grapples with earnings reports and renewed U.S.-China trade tensions, major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 have ended lower. In such uncertain times, dividend stocks can offer a reliable income stream for investors seeking stability amidst market volatility.

SouthState Bank (SSB) grew earnings by 39.8% year-over-year, reaching net profit margins of 29.9%, just above last year’s 29.8%. Looking ahead, earnings are forecast to rise at 17.8% per year, outpacing the US market’s projected 15.5% annual growth. Revenue is set to trail the national pace at 8.8% growth per year versus the broader forecast of 10%. With profits climbing and net margins holding strong, investors have reasons to be optimistic about the bank’s renewed momentum. See our full...

Gilat Satellite Networks (NasdaqGS:GILT) just revealed $42 million in fresh orders for its SkyEdge IV platform, with delivery set for the coming year. This sizeable deal shows accelerating demand for advanced satellite connectivity solutions across sectors. See our latest analysis for Gilat Satellite Networks. This latest $42 million order comes as Gilat Satellite Networks enjoys a burst of positive momentum, highlighted by the company’s recent showcase at the 2025 Annual Meeting &...

Thinking about making a move on Travere Therapeutics? You’re not alone. With the stock up a stunning 48.4% year-to-date and a 55.6% rally over the past year, plenty of investors are taking notice. The last month alone brought a jump of 16.2%, and even shorter-term momentum has been strong, with a 2.3% gain in the last week. Naturally, these big price moves have sparked fresh debates about whether the stock’s growth story is just beginning or if it is already priced in. Fueling that discussion...

Packaging Corporation of America (PKG) delivered a net profit margin of 10.4%, notably up from last year’s 9%, as EPS rose alongside earnings growth of 26% over the past year. Over the past five years, earnings have climbed at an average annual rate of 6.6%, with profit growth expected to continue at 9.1% per year moving forward. For investors, the current appeal centers on ongoing profitability, resilient dividends, and a share price trading below estimated fair value. See our full analysis...

Lazard (LAZ) delivered a standout earnings performance, with EPS soaring 99.5% year over year and net profit margins climbing to 9.9% from 5.5% last year. Investors eyeing future growth may find reason for optimism, as earnings are forecast to rise 32.3% annually and revenue is projected to grow 12.8% per year. Both of these figures are expected to outpace the broader US market. With the shares trading below fair value and valuation metrics undercutting industry averages, the balance of...

World Acceptance (WRLD) posted net profit margins of 14.3%, edging out last year's 13.8%, while annual earnings grew 4.4% and have averaged 5% growth per year over the last five years. Looking forward, analysts see earnings rising 15.98% per year, which slightly outpaces the projected 15.5% annual growth rate for the US market. However, revenue growth is expected to lag at 6.1% per year compared to the broader market’s 10% rate. With margins holding strong and a solid track record of profit...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

American Airlines Group (AAL) has returned to profitability, growing earnings at an impressive 73.9% annual rate over the past five years. Looking ahead, analysts forecast earnings will continue to surge at about 40.7% per year, well ahead of the broader US market's growth rate. Revenue, however, is expected to rise by a more modest 4.7% annually compared to the US market's 10%. The latest twelve-month results include a significant one-off loss of $689 million. This makes the path to...

USANA Health Sciences (USNA) is expected to deliver standout annual earnings growth of 80.5% per year, a rapid rebound compared to the US market average of 15.5% per year. Despite this bullish outlook, revenue is projected to expand just 1.6% per year, trailing the broader market’s 10% trend, and the company currently operates at a net profit margin of 1.9%, down significantly from 6.3% a year ago, after five years of annual earnings declines averaging 28.6%. These headline figures highlight...

Southwest Airlines (LUV) has returned to profitability with an impressive annual earnings growth rate of 52.9% over the past five years. Looking ahead, the company is projected to deliver annual earnings growth of 40.3%, which is more than double the broader US market's expected 15.5% pace. While revenue growth is forecast at 6.1% per year, Southwest's margin improvements and shift to high-quality earnings have clearly strengthened its fundamentals, even as investors scrutinize valuation and...

UniFirst (UNF) reported a current net profit margin of 6.1%, slightly higher than last year’s 6%. Earnings growth reached 2% over the past year, outpacing its five-year average increase of 1.4% per year. Looking ahead, the company is forecasting annual earnings growth of 2.4% and revenue growth of 3.2%, both of which remain well below broader US market expectations. With no notable risks flagged, investors may view this release as a sign of steady profitability and attractive value metrics...

Selective Insurance Group (SIGI) just posted standout earnings, with net profit margin jumping to 7.6% from 4.8% and earnings up an impressive 75% over the past year. This far outpaces its five-year average, which saw declines of 1.5% per year. Investors are taking note of the company's supported margins and attractive P/E ratio of 11.7x. Looking ahead, forecasts call for annual earnings growth of 13.09% and revenue growth of 5.9%. Both figures trail the broader US market but underscore clear...

Millrose Properties (MRP) has swung to profitability over the past five years, highlighted by a one-off gain of $25.0 million in the most recent numbers to September 30, 2025. Investors will likely focus on the company’s projected 16.9% annual revenue growth and 21.4% annual expansion in earnings. Both figures are well ahead of the US market’s expected pace, although these headline numbers reflect the effects of a recent move to profitability and include notable non-recurring items. See our...

Kinder Morgan (KMI) posted forecasted earnings growth of 8.1% per year and revenue growth of 6.3% per year, both trailing the broader US market averages. The company’s net profit margin stands at 16.5%, just below the previous year’s figure, and recent earnings growth of 7.4% lags its five-year average of 18.8%. Currently, shares change hands at $26.25, notably below an estimated fair value of $39.06, while the price-to-earnings ratio of 21.5x outpaces both peers and the industry. See our...

Visteon (VC) posted revenue growth forecasts of 4.8% per year, which lags the broader US market average of 10%. Net profit margin came in at 7.6%, slipping from last year’s 13.8%, while earnings are only expected to grow at 7.1% per year compared to the market’s 15.5% pace. Over the past five years, annual earnings grew quickly, but the most recent year saw earnings decline, and shares now trade at $110.22, notably below the company's fair value estimate of $157.77. With decent value metrics...

Earlier this week, Verastem Oncology announced promising preliminary data from the Phase 1/2a clinical trial of VS-7375, an oral KRAS G12D inhibitor, in patients with advanced KRAS G12D mutant solid tumors, along with the initiation of a combination cohort with cetuximab. These findings are significant, as there are currently no FDA-approved therapies specifically targeting KRAS G12D mutations in cancer, addressing a critical gap for patients with limited treatment options. We'll explore how...